Wall Street brokerages forecast that Docusign Inc (NASDAQ:DOCU) will post sales of $208.49 million for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates for Docusign’s earnings. The highest sales estimate is $213.09 million and the lowest is $206.40 million. Docusign posted sales of $155.81 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 33.8%. The firm is scheduled to announce its next earnings results on Thursday, June 6th.
According to Zacks, analysts expect that Docusign will report full year sales of $913.96 million for the current financial year, with estimates ranging from $912.20 million to $920.16 million. For the next fiscal year, analysts anticipate that the company will post sales of $1.13 billion, with estimates ranging from $1.10 billion to $1.14 billion. Zacks’ sales calculations are a mean average based on a survey of research analysts that cover Docusign.
Docusign (NASDAQ:DOCU) last issued its quarterly earnings data on Thursday, March 14th. The company reported ($0.24) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.23) by ($0.01). The company had revenue of $199.73 million for the quarter, compared to analyst estimates of $193.63 million. Docusign had a negative net margin of 60.84% and a negative return on equity of 86.06%. Docusign’s revenue for the quarter was up 34.2% on a year-over-year basis.
In other Docusign news, insider Kirsten O. Wolberg sold 10,166 shares of the firm’s stock in a transaction that occurred on Monday, March 25th. The stock was sold at an average price of $52.95, for a total value of $538,289.70. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, COO Scott V. Olrich sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $53.39, for a total value of $533,900.00. The disclosure for this sale can be found here. Insiders sold a total of 40,883 shares of company stock worth $2,212,890 in the last ninety days.
Large investors have recently made changes to their positions in the company. Sonora Investment Management LLC acquired a new stake in shares of Docusign during the 1st quarter worth approximately $31,000. Clean Yield Group acquired a new stake in shares of Docusign during the 1st quarter worth approximately $31,000. Legacy Advisors LLC acquired a new stake in shares of Docusign during the 1st quarter worth approximately $38,000. Private Capital Group LLC grew its holdings in shares of Docusign by 173.0% during the 4th quarter. Private Capital Group LLC now owns 819 shares of the company’s stock worth $33,000 after purchasing an additional 519 shares in the last quarter. Finally, Parallel Advisors LLC grew its holdings in shares of Docusign by 244.1% during the 4th quarter. Parallel Advisors LLC now owns 905 shares of the company’s stock worth $36,000 after purchasing an additional 642 shares in the last quarter. 52.71% of the stock is currently owned by institutional investors.
Shares of NASDAQ DOCU traded down $0.45 during mid-day trading on Friday, reaching $53.05. 1,270,035 shares of the company traded hands, compared to its average volume of 1,587,127. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.91 and a current ratio of 1.91. The firm has a market cap of $9.27 billion and a price-to-earnings ratio of -18.29. Docusign has a fifty-two week low of $35.06 and a fifty-two week high of $68.35.
Docusign Company Profile
DocuSign, Inc provides cloud based software in the United States. The company offers e-signature solution that enables businesses to digitally prepare, execute, and act on agreements. The company sells its products through direct, partner-assisted, and Web-based sales. It serves enterprise businesses, commercial businesses, and small businesses, such as professionals, sole proprietorships and individuals.
Featured Story: Determine Your Level of Risk Tolerance
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.